Papers/PMID:32951697
The effect of melatonin supplementation on liver indices in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized clinical trials.
Complementary therapies in medicine2020The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
melatonin — no detected effect on alanine aminotransferase
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Melatonin had no significant effect on alanine aminotransferase (ALT) regarding the overall effect size.”
Quoted verbatim from The effect of melatonin supplementation on liver indices in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized clinical trials.. - Study
- meta-analysis
- Population
- Patients with non-alcoholic fatty liver disease (NAFLD) (meta-analysis of RCTs, melatonin vs placebo)
The effect of melatonin supplementation on liver indices in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized clinical trials.2020PMID:32951697Permalink